Programmed Death Receptor-1 Blocking Antibody [EPC] - N0000191260

Pharmacologic Code	N0000191260
Pharmacologic Name	Programmed Death Receptor-1 Blocking Antibody
Pharmacologic Uses	human programmed death receptor-1 (PD-1)-blocking antibody programmed death receptor-1 (PD-1)-blocking antibody
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 16 products whose active ingredient are classified under the same pharmacologic class Programmed Death Receptor-1 Blocking Antibody [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0003-3734	Opdivo	Non-Proprietary Name: Nivolumab	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-3756	Opdivo	Non-Proprietary Name: Nivolumab	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-3772	Opdivo	Non-Proprietary Name: Nivolumab	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-3774	Opdivo	Non-Proprietary Name: Nivolumab	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-6120	Opdivo Qvantig	Non-Proprietary Name: Nivolumab And Hyaluronidase-nvhy	Injection, Solution	Subcutaneous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0003-7125	Opdualag	Non-Proprietary Name: Nivolumab And Relatlimab-rmbw	Injection	Intravenous	E.r. Squibb & Sons, L.l.c.	ACTIVE
	0006-3026	Keytruda	Non-Proprietary Name: Pembrolizumab	Injection, Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
	0006-3083	Keytruda Qlex	Non-Proprietary Name: Pembrolizumab And Berahyaluronidase Alfa-pmph	Injection, Solution	Subcutaneous	Merck Sharp & Dohme Llc	ACTIVE
	0006-5083	Keytruda Qlex	Non-Proprietary Name: Pembrolizumab And Berahyaluronidase Alfa-pmph	Injection, Solution	Subcutaneous	Merck Sharp & Dohme Llc	ACTIVE
	0173-0898	Jemperli	Non-Proprietary Name: Dostarlimab	Injection	Intravenous	Glaxosmithkline Llc	ACTIVE
	50242-917	Tecentriq	Non-Proprietary Name: Atezolizumab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-918	Tecentriq	Non-Proprietary Name: Atezolizumab	Injection, Solution	Intravenous	Genentech, Inc.	ACTIVE
	50242-933	Tecentriq Hybreza	Non-Proprietary Name: Atezolizumab And Hyaluronidase-tqjs	Injection	Subcutaneous	Genentech, Inc.	ACTIVE
	50881-006	Zynyz	Non-Proprietary Name: Retifanlimab-dlwr	Injection	Intravenous	Incyte Corporation	ACTIVE
	70114-340	Loqtorzi	Non-Proprietary Name: Toripalimab-tpzi	Injection	Intravenous	Coherus Biosciences, Inc.	ACTIVE
	72579-121	Tevimbra	Non-Proprietary Name: Tislelizumab-jsgr	Injection, Solution, Concentrate	Intravenous	Beone Medicines Usa, Inc.	ACTIVE